| Active Hormone |
Somatropin |
| Total Strength |
240 IU |
| Drug Category |
Human growth hormone |
| Manufacturer |
Pfizer |
| Peptide Length |
191 amino acids |
| Molecular Mass |
≈22 kDa |
| Administration Type |
Subcutaneous injection |
| Dosage Form |
Lyophilized powder cartridge |
| Pharmaceutical Technology |
Recombinant DNA |
| Therapeutic Indication |
Growth disorders |
| Hormonal Function |
Stimulates tissue growth |
| Biological Target |
Growth hormone receptors |
| Metabolism |
Liver and kidney |
| Clearance Method |
Renal excretion |
| Injection Device |
Pen injector compatible |
| Stability Requirement |
Refrigeration |
| Solution Appearance |
Clear after reconstitution |
| Hormone Type |
Somatropin recombinant |
| IU Measurement |
240 International Units |
| Biological Source |
E. coli recombinant expression |
| Protein Category |
Endocrine peptide hormone |
| Growth Pathway |
IGF-1 stimulation |
| Absorption Route |
Subcutaneous tissue |
| Distribution |
Systemic bloodstream |
| Plasma Protein Binding |
Minimal |
| Pharmacokinetic Profile |
Short systemic half-life |
| Solution Preparation |
Dilution before use |
| Injection Frequency |
Physician prescribed |
| Treatment Area |
Pediatric growth disorders |
| Hormone Replacement Role |
GH deficiency therapy |
| Manufacturing Technology |
Biotechnology fermentation |
| Quality Standard |
Pharmaceutical grade |
| Stability Factor |
Temperature sensitive |
